Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Nocimed is a medical device company focused on developing objective diagnostic tests for chronic pain. Their technology aims to provide clinicians with valuable information to improve patient care and outcomes by identifying the source of pain. This approach has the potential to revolutionize the way chronic pain is diagnosed and treated, leading to more effective therapies and improved quality of life for patients.
Serves as the central hub for Nocimed's research and development, executive leadership, and administrative functions.
While specific details about the headquarters' architectural features are not publicly available, it is likely a modern office space designed to foster collaboration and innovation. The office likely houses laboratories and research facilities necessary for developing their diagnostic technologies.
Based on the company's mission and focus on innovation in healthcare, the work culture at Nocimed's headquarters is likely collaborative, fast-paced, and results-oriented. Employees are likely passionate about improving patient outcomes and contributing to advancements in pain management.
The headquarters' location in Menlo Park positions Nocimed in the heart of Silicon Valley, providing access to talent, funding, and a vibrant ecosystem of innovation in healthcare and technology.
While primarily based in the United States, Nocimed likely engages in global collaborations with research institutions and healthcare providers to advance its technology and market its diagnostic tests internationally. Their products are aimed for the global markets.
65 Willow Pl
Menlo Park
CA
USA
Address: Address is to be added
To focus on expanding reach within the California market.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Nocimed' leadership includes:
Nocimed has been backed by several prominent investors over the years, including:
There is no readily available information regarding significant executive new hires or exits at Nocimed within the last 12 months. Public information about executive changes in privately held companies like Nocimed is often limited.
Discover the tools Nocimed uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Nocimed's email format is likely a combination of first name initial and last name at their domain.
[first_initial][last]@nocimed.com
Format
bouyang@nocimed.com
Example
Unknown%
Success rate
No recent news available.
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Nocimed, are just a search away.